Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
VT

VTRS

Market Closed

Viatris Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic
US
30.00K employees
CEO: Scott Andrew Smith
Founded: 1980
$16.43
+$0.00(+NaN%)
Market Cap
19.13B
Beta
0.90
52W Range
N/A
Dividend Yield
2.92%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Viatris’ current price of $17.73 lies below the fair value estimate of $20.88, indicating potential undervaluation with a high-confidence upside near 18%. Financial health is poor, with zero profitability and efficiency but moderate liquidity and leverage, raising concerns about operational stability. Monte Carlo analysis shows high volatility (45% coefficient of variation) but limited downside risk (22%), reflecting significant uncertainty balanced by upside potential.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore VTRS

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

VTRS in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →